YGION Biomedical GmbH

YGION Biomedical is an Austrian biotechnology company, dedicated to make individualized cancer immunotherapy a reality.  By applying groundbreaking, innovative technologies, we strive to provide better and more effective treatments to cancer patients.

Our approach encompasses a targeted activation of the patient’s immune system, promising to elicit a fast, strong, and long-lasting specific immune response with an excellent safety profile.

We believe that directing the patient’s immune system specifically against the tumor will provide protection against tumor relapse and metastasis and thus represents a promising opportunity to improve long-term control of cancer progression.